HOTH
Companies
NASDAQ
Hoth Therapeutics Inc.
Health Care
$1.34
+$0.50 (+67.11%)
Price Chart
Overview
About HOTH
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
Market Cap
$5.3M
Volume
360.0K
Avg. Volume
374.0K
P/E Ratio
-1.2115493
Dividend Yield
0.00%
Employees
4.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.67
Low Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, HOTH shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$5.3M
Volume360.0K
P/E Ratio-1.21
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 13, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025